; and (B) provide an opportunity for public comment on the proposed list or update. (2) Initial list The Secretary shall— (A) publish the proposed initial list under subsection (a) not later than 6 months after the date of enactment of this Act; and (B) publish the final initial list under subsection (a) not later than 1 year after such date of enactment. (3) Regular review The Secretary shall regularly review the list under subsection (a) to determine whether any updates should be made pursuant to paragraph (1). (e) Relation to Executive Order The participation of the Secretary in establishing, maintaining, and updating the list under subsection (a) shall be deemed to be full satisfaction of the requirements applicable to the Secretary under section 3 of Executive Order 13944 (85 Fed. Reg. 49929). 3. Federal United States pharmaceutical supply chain mapping (a) In general The Secretary of Health and Human Services, in coordination with the heads of other relevant agencies, shall support efforts, including through public-private partnerships, to map the entire United States pharmaceutical supply chain, from inception to distribution, and use data analytics to identify supply chain vulnerabilities and other national security threats. Such activities shall include, at a minimum— (1) defining agency roles in monitoring the pharmaceutical supply chain and communicating supply chain vulnerabilities; and (2) with respect to drugs and active pharmaceutical ingredients on the list of essential medicines under section 2(a), establishing a database that shall include— (A) the location of establishments registered under subsection (b), (c), or (i) of section 510 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360 ) involved in the production of— (i) the finished dosage forms of the drugs on such list; (ii) the active pharmaceutical ingredients of such drugs; or (iii) active pharmaceutical ingredients on such list